Biotechnology Fund Valuation
| RYOAX Fund | USD 64.45 10.45 19.35% |
At this time, the entity appears to be fairly valued. Biotechnology Fund Class shows a prevailing Real Value of $63.56 per share. The current price of the fund is $64.45. We determine the value of Biotechnology Fund Class from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Fairly Valued
Today
Please note that Biotechnology Fund's price fluctuation is very steady at this time. At this time, the entity appears to be fairly valued. Biotechnology Fund Class shows a prevailing Real Value of $63.56 per share. The current price of the fund is $64.45. We determine the value of Biotechnology Fund Class from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Since Biotechnology Fund is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biotechnology Mutual Fund. However, Biotechnology Fund's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 64.45 | Real 63.56 | Hype 64.45 |
The intrinsic value of Biotechnology Fund's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Biotechnology Fund's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Biotechnology Fund Class helps investors to forecast how Biotechnology mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biotechnology Fund more accurately as focusing exclusively on Biotechnology Fund's fundamentals will not take into account other important factors: Biotechnology Fund Total Value Analysis
Biotechnology Fund Class is at this time forecasted to have takeover price of 0 with market capitalization of 0, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Biotechnology Fund fundamentals before making investing decisions based on enterprise value of the companyBiotechnology Fund Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Biotechnology suggests not a very effective usage of assets in December.About Biotechnology Fund Valuation
Our relative valuation model uses a comparative analysis of Biotechnology Fund. We calculate exposure to Biotechnology Fund's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Biotechnology Fund's related companies.Under normal circumstances, the fund invests substantially all of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.
Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Fund financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Fund security.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |